Compounded Semaglutide

product on 1 show · 1 statements across 1 episodes

TBPN

1 statements about Compounded Semaglutide, every show

TBPN Insight
Coogan: Compounded semaglutide revenue risks elimination once FDA drug shortages end
“The other issue with the compounding just from a business perspective is that I think that you're only allowed to do it from an FDA perspective when it's on shortage. And so you can build up this revenue stream and you can get subscribers, but then it could ge…”
John Coogan Nov 19, 2024 ▶ 1:12:45 Who's Getting Rich Off Ozempic? (e12)

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.